mAbsolve
Biotechnology Research • 
Oxford, England, United Kingdom • 1-10 Employees
Company overview
| Headquarters | Oxford, England, United Kingdom |
| Phone number | +4412347440 |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Licensing, Monoclonal Antibodies, Antibody Engineering, Immunogenicity, Complement, Cytokine Release, Fc Fusion Proteins, Fc Receptors |
| Founded | 2019 |
| Employees | 1-10 |
| Socials |
Key Contacts at mAbsolve
Geoff Hale
Chief Executive Officer
Mike Clark
Founder Investor And Scientific Advisor
About mAbsolve
Our founders were pioneers of monoclonal antibody therapy, bringing to the clinic the first humanised antibody, the first made in CHO cells, the first bispecific and the first aglycosylated antibody. Now we have developed a new Fc variant which is more comprehensively silenced than previous antibodies. It is able to reduce unwanted inflammatory responses from the next generation of antibody-based drugs. We are building partnerships with Universities, Biotech and Pharma companies to make this new technology widely available.
mAbsolve revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
mAbsolve has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
mAbsolve has never raised funding before.
mAbsolve Tech Stack
Discover the technologies and tools that power mAbsolve's digital infrastructure, from frameworks to analytics platforms.
Security
WordPress plugins
Analytics
JavaScript libraries
JavaScript libraries
WordPress themes
Programming languages
Security
Blogs
Hosting
Analytics
Cookie compliance
United States
Czechia
Australia
Frequently asked questions
4.8
40,000 users
